EGFR is a key factor in driving EMT, and earlier research has shown that sialylation of EGFR by ST6Gal-I encourages both basal and ligand-dependent EGFR activation in pancreatic and ovarian cancer cells [54]. Here, ST6GAL1 is linked to ovarian carcinoma.